Company News in the Life Science Industry

»

Reset 

BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  BioSig Technologies, Inc.

Tiziana Life Sciences Interview to Air on Bloomberg International on the RedChip Money Report

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  Tiziana Life Sciences plc

Rossari First IPO to do Virtual Roadshow

Companies adopt Virtual Roadshows for Capital Raise

Read more ››
By: PR Newswire Association LLC. - 10 Jul 2020

CS02 Changes the Landscape of Diabetes Treatment: CenterLab Announces Positive Topline Results of Phase 2 Trial

TAIPEI, July 10, 2020 /PRNewswire/ -- Center Laboratories Inc. (CenterLab: 4123.TWO), a pharmaceutical company dedicated in specialty drug product development, announced today that the anti-diabetic drug - CS02 meets its primary endpoint. The topline results of a phase 2 clinical trial of CS02... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

Welcome to NETX - Global Conglomerate Bellagraph Nova Group Launches Latest Technolgy Platform Focusing on AI + Robotics + Healthcare

PARIS, July 10, 2020 /PRNewswire/ -- Headquartered in Paris, France, the Bellagraph Nova Group (BN Group), the multi-national conglomerate overseeing 31 business entities across 100 countries is the world's fastest growing 360 degree lifestyle platform.

Read more ››
By: PR Newswire Association LLC. - 10 Jul 2020

AGENT Study Update With Regards to COVID-19

GOTHENBURG, Sweden, July 10, 2020 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq First North Premier Growth Market: ISOFOL), informs that the outbreak of COVID-19 has affected the general situation of the AGENT study activities. Patient recruitment has been ongoing without interruption during... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020
Related companies:  Isofol Medical AB

World's First FDA IDE Coronary Patient Treated With a DEB

NYON, Switzerland, July 10, 2020 /CNW/ -- MedAlliance has announced enrollment of the first patient in its study of SELUTION SLR(TM) 014 DEB for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

EU Approval Of Mesenchymal Stromal Cell Therapy Manufacturing Protocol Using nLiven Human Platelet Lysate For A Phase 1B Clinical Trial

INDIANAPOLIS and GALWAY, Ireland, July 10, 2020 /PRNewswire/ -- The Centre for Cell Manufacturing Ireland (CCMI) at the National University of Ireland Galway (NUI Galway) and Sexton Biotechnologies today announced the approval by an EU Regulatory Authority of a protocol for the manufacture of... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

Partnering For Success: HabitNu and Community Health Innovations Establish a First-Of-Its-Kind Umbrella Organization Model to Deliver the CDC-Recognized Diabetes Prevention Program (DPP)

CHICAGO, July 10, 2020 /PRNewswire/ -- HabitNu is pleased to announce that it has received Diabetes Prevention Recognition Program (DPRP) umbrella status recognition by the Centers for Disease Control and Prevention (CDC). The umbrella arrangement was recently introduced by the CDC so that organizations... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

"Never Give Up Youth Healing Center" of Las Vegas Launches Podcast to Help Leaders Achieve Their Higher Purpose

LAS VEGAS, July 10, 2020 /PRNewswire/ -- The Never Give Up Youth Healing Center of Las Vegas helps... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

Healthcare Practitioners Adapt to New Challenges with Innovative Devices

NEW YORK, July 10, 2020 /PRNewswire/ -- Healthcare systems around the world and in the United States have been under severe pressure in recent months as the global pandemic continues to spread. To help maintain the infrastructure and provide quality care to as many patients as possible, healthcare... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

Global Digital Pathology Market Assessment 2020-2025 - Market Expected to Cross $1.1 Trillion by 2025, with North America Growing at the Highest Rate

DUBLIN, July 10, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

World-Renowned Transplant Surgeon to Lead Department of Surgery at NYU Langone Health

NEW YORK, July 10, 2020 /PRNewswire/ -- Robert A. Montgomery, MD, DPhil,... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020
Related companies:  NYU Langone Health | NYU Langone Medical Center- Cytometry & Cell Sorting Laboratory

PURA Confirms Acquisition Set to Deliver Shareholder Dividend Scheduled to Close Today

DALLAS, July 10, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) confirmed that the previously announced management buyout of a separate public company that will in turn purchase PURA's cannabis cultivation spinoff in exchange for common stock is scheduled to close today. The common stock issued... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

New England Biolabs' SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Novel Coronavirus In 30 Minutes

IPSWICH, Mass., July 10, 2020 /PRNewswire/ -- New England Biolabs(®) (NEB(®)) today announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the detection of novel coronavirus, SARS-CoV-2 RNA. The kit serves as a simple... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020
Related companies:  New England Biolabs

Orsini Pharmaceutical Services Expands Partnership With Ultragenyx To Provide Dojolvi(TM) (triheptanoin) - For Patients With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)

ELK GROVE VILLAGE, Ill., July 10, 2020 /PRNewswire/ -- Orsini Pharmaceutical Services ("Orsini"), a leading independent national specialty pharmacy focused on patients with rare and complicated diseases, announced today that it has been selected by Ultragenyx Pharmaceutical Inc. as a limited... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020
Related companies:  Orsini Healthcare | Ultragenyx Pharmaceutical Inc.

Coronavirus (COVID-19) Update: FDA prepares for resumption of domestic inspections with new risk assessment system

SILVER SPRING, Md., July 10, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration has been thoughtfully and deliberately determining the safest and most appropriate time to resume prioritized domestic inspections of FDA-regulated facilities and other associated activities since we first... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020
Related companies:  U.S. Food and Drug Administration

Protective Clothing Market Worth $12.3 Billion by 2025 - Exclusive Report by MarketsandMarkets™

CHICAGO, July 10, 2020 /PRNewswire/ -- According to the new market research report "Protective Clothing... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

BLU Investor Update: Bronstein, Gewirtz & Grossman, LLC Notifies BELLUS Health Inc. Investors of Investigation and Encourages Investors to Contact the Firm

NEW YORK, July 10, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BELLUS Health Inc. ("BELLUS" or "the Company") (NASDAQ: BLU). Investors who purchased BELLUS securities are encouraged to obtain... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies